Electrocardiographic changes associated with insulin resistance

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 3, 2014, Pages 315-320

  Graner M ^a   Pentikainen M O ^a   Siren, R ^b   Nyman, K ^c   Lundbom, J ^c   Hakkarainen, A ^c   Lauerma, K ^c   Lundbom, N ^c   Nieminen, M S ^a   Taskinen, M R ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b City of Helsinki   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cardiac steatosis; Electrocardiogram; Metabolic syndrome

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY FAT; BODY MASS; CARDIOVASCULAR MAGNETIC RESONANCE; ELECTROCARDIOGRAPHY; EPICARDIUM; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE; HEART MUSCLE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERICARDIUM; PRIORITY JOURNAL; QRS COMPLEX; STEATOSIS; WAIST CIRCUMFERENCE;

CARDIAC STEATOSIS; ELECTROCARDIOGRAM; METABOLIC SYNDROME;

ADIPOSITY; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FASTING; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INSULIN RESISTANCE; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; OBESITY; RETROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84895782975     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.09.013     Document Type: Article

References (27)

1. De Bacquer D., De Backer G., Kornitzer M., Blackburn H. Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease in men and women. Heart 1998, 80:570-577.
2. Kannel W.B., Anderson K., McGee D.L., Degatano L.S., Stampfer M.J. Nonspecific electro-cardiographic abnormality as a predictor of coronary heart disease: the Framingham study. Am Heart J 1987, 113:370-376.
3. Fraley M.A., Birchem J.A., Senkottaiayan N., Alpert M.A. Obesity and the electrocardiogram. Obes Rev 2005, 6:275-281.
4. Szczepaniak L.S., Dobbins R.L., Metzger G.J., Sartoni-D'Ambrosia G., Arbique D., Vongpatanasin W., et al. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 2003, 49:417-423.
5. Kankaanpää M., Lehto H.R., Pärkkä J.P., Komu M., Viljanen A., Ferrannini E., et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 2006, 91:4689-4695.
6. Iozzo P., Lautamaki R., Borra R., Lehto H.R., Bucci M., Viljanen A., et al. Contribution of glucose tolerance and gender to cardiac adiposity. J Clin Endocrinol Metab 2009, 94:4472-4482.
7. McGavock J.M., Lingvay I., Zib I., Tillery T., Salas N., Unger R., et al. Cardiac steatosis in diabetes mellitus. A 1H-Magnetic resonance spectroscopy study. Circulation 2007, 116:1170-1175.
8. Iozzo P. Metabolic toxicity of the heart: insights from molecular imaging. Nutr Metab Cardiovasc Dis 2010, 20:147-156.
9. Gastaldelli A., Basta G. Ectopic fat and cardiovascular disease: what is the link?. Nutr Metab Cardiovasc Dis 2010, 20:481-490.
10. Wende A.R., Abel E.D. Lipotoxicity in the heart. Biochim Biophys Acta 2010, 1801:311-319.
11. Alberti K.G.M.M., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic Syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the study of obesity. Circulation 2009, 120:1640-1645.
12. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
13. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modelling. Diabetes Care 2004, 27:1487-1495.
14. Granér M., Siren R., Nyman K., Lundbom J., Hakkarainen A., Pentikäinen M.O., et al. Cardiac steatosis associates with visceral obesity in nondiabetic obese men. J Clin Endocrinol Metab 2013, 98:1189-1197.
15. Mewton N., Opdahl A., Choi E.Y., Almeida A., Kawel N., Wu C., et al. Left ventricular global function index by magnetic resonance imaging - a novel marker for assessment of cardiac performance for the prediction of cardiovascular events. The Multi-Ethnic Study of Atherosclerosis. Hypertension 2013, 61:770-778.
16. Alpert M.A., Terry B.E., Cohen M.V., Fan T.M., Painter J.A., Massey C.V. The electrocardiogram in morbid obesity. Am J Cardiol 2000, 85:908-910.
17. Bacharova J., Krivosikova Z., Wsolova L., Gajdos M. Alterations in the QRS complex in the offspring of patients with metabolic syndrome and diabetes mellitus: early evidence of cardiovascular pathology. J Electrocardiol 2012, 45:244-251.
18. Magnani J.W., Lopez F.L., Soliman E.Z., Maclehose R.F., Crow R.S., Alonso A. P wave indices, obesity and the metabolic syndrome: the atherosclerosis risk in communities study. Obesity 2012, 20:666-672.
19. Babcock M.J., Soliman E.Z., Ding J., Kronmal R.A., Goff D.C. Pericardial fat and atrial conduction abnormalities in the multiethnic study of atherosclerosis (MESA). Obesity 2011, 19:179-184.
20. Shirani J., Berezowski K., Roberts W.C. Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage. Am J Cardiol 1995, 76:414-418.
21. Frank S., Colliver J.A., Frank A. The electrocardiogram in obesity: statistical analysis of 1,029 patients. J Am Coll Cardiol 1986, 7:295-299.
22. Brohet C.H., Tuna N. Quantitative analysis of the vectorcardiogram in obesity. The effects of weight reduction. J Electrocardiol 1975, 8:1-11.
23. Kim H.K., Kim C.H., Ko K.H., Park S.W., Park J.Y., Lee K.P. Variable association between components of the metabolic syndrome and electrocardiographic abnormalities in Korean adults. Korean J Intern Med 2010, 25:174-180.
24. Ebong I., Bertoni A.G., Soliman E.Z., Guo M., Sibley C.T., Chen Y.I., et al. Electrocardiographic abnormalities associated with the metabolic syndrome and its components: the multi-ethnic study of atherosclerosis. Metab Syndr Relat Disord 2012, 10:92-97.
25. Iozzo P. Myocardial, perivascular, and epicardial fat. Diabetes Care 2011, 34:S371-S379.
26. Utz W., Engeli S., Haufe S., Kast P., Hermsdorf M., Wiesner S., et al. Myocardial steatosis, cardiac remodelling and fitness in insulin-sensitive and insulin-resistant obese women. Heart 2011, 97:1585-1589.
27. Nicolini E., Martegani G., Maresca A.M., Marchesi C., Dentali F., Lazzarini A., et al. Left ventricular remodeling in patients with metabolic syndrome: influence of gender. Nutr Metab Cardiovasc Dis 2013, 23:771-775.